Modern Diagnostic & Research Centre IPO Subscription Status

Detailed category-wise subscription breakdown with historical data

About Modern Diagnostic & Research Centre IPO Subscription

Track the Modern Diagnostic & Research Centre IPO subscription status with comprehensive data across all investor categories. The IPO subscription window was open from Dec 31, 2025 to Jan 02, 2026. Subscription data is categorized into Qualified Institutional Buyers (QIB), Non-Institutional Investors (NII), and Retail Individual Investors (Retail).

The NII category is further divided into bNII (bids above ₹10 lakh) and sNII (bids below ₹10 lakh) to provide granular insights into subscription patterns. The overall subscription for Modern Diagnostic & Research Centre IPO stands at 826.00 times.

Subscription rates indicate the level of investor interest - a higher subscription multiple suggests strong demand, while lower multiples may indicate moderate interest. This data helps investors understand market sentiment and make informed decisions about the IPO.

Latest Subscription Snapshot

As of January 02, 2026

Total Subscription

826.00×

Investor Category	Shares Offered	Shares Bid For	Subscribed (Times)	No. of Applications
QIB Qualified Institutional Buyers	683,200	185,238,400	271.13×	427
NII Non-Institutional Investors	513,600	753,851,200	1,467.78×	321
bNII Bids above ₹10L	342,400	609,716,800	1,780.71×	214
sNII Bids below ₹10L	171,200	144,134,400	841.91×	107
Retail Investors Retail Individual Investors	1,200,000	1,040,672,000	867.23×	750
Total	2,396,800	1,979,761,600	826.00×	1,819

Subscription History

Historical subscription data grouped by date

Jan 02, 2026

Friday

Category	Shares Offered	Shares Bid For	Times	No. of Applications
QIB	683,200	185,238,400	271.13×	427
NII	513,600	753,851,200	1,467.78×	321
bNII	342,400	609,716,800	1,780.71×	214
sNII	171,200	144,134,400	841.91×	107
Retail	1,200,000	1,040,672,000	867.23×	750
Total	2,396,800	1,979,761,600	826.00×	1,819

Jan 01, 2026

Thursday

Category	Shares Offered	Shares Bid For	Times	No. of Applications
QIB	782,400	6,998,400	8.94×	—
bNII	393,600	24,961,600	63.42×	—
sNII	192,000	6,201,600	32.30×	—
Individual Investors	1,363,200	46,140,800	33.85×	—
Anchor	1,161,600	1,161,600	1.00×	—
Others	206,400	206,400	1.00×	—
Total	2,145,600	53,139,200	24.77×	—

Frequently Asked Questions about Modern Diagnostic & Research Centre IPO IPO Subscription

Common questions and answers about Modern Diagnostic & Research Centre IPO subscription status, dates, and allotment

What is the current subscription status of Modern Diagnostic & Research Centre IPO IPO?

As of January 02, 2026, the Modern Diagnostic & Research Centre IPO IPO has been subscribed 826.00 times overall. The IPO is fully subscribed with strong investor demand indicating extremely high interest. A total of 1,819 applications have been received across all investor categories.

When was the Modern Diagnostic & Research Centre IPO IPO subscription window open?

The Modern Diagnostic & Research Centre IPO IPO subscription window was open from December 31, 2025 to January 02, 2026. Investors could apply for shares during this period through their demat account or ASBA facility.

What is the price band and minimum investment for Modern Diagnostic & Research Centre IPO IPO?

The Modern Diagnostic & Research Centre IPO IPO has a price band of ₹85 to ₹90 per share. The lot size is 1,600 shares, which means retail investors need to apply for a minimum of 1,600 shares. The minimum investment required is ₹136,000 (at lower price) or ₹144,000 (at upper price).

What is the QIB subscription for Modern Diagnostic & Research Centre IPO IPO?

The Qualified Institutional Buyers (QIB) category for Modern Diagnostic & Research Centre IPO IPO has been subscribed 271.13 times. QIBs were offered 683,200 shares in this IPO. QIB category includes foreign institutional investors (FIIs), domestic mutual funds, banks, insurance companies, and other qualified institutional investors. The strong QIB subscription indicates high institutional investor confidence in Modern Diagnostic & Research Centre IPO.

What is the Retail subscription for Modern Diagnostic & Research Centre IPO IPO?

The Retail Individual Investors (RII) category for Modern Diagnostic & Research Centre IPO IPO has been subscribed 867.23 times. Retail investors were offered 1,200,000 shares in this IPO. Retail category includes individual investors applying for shares up to ₹2 lakh. The high retail subscription reflects strong interest from small investors in Modern Diagnostic & Research Centre IPO IPO.

What is the NII subscription for Modern Diagnostic & Research Centre IPO IPO?

The overall Non-Institutional Investors (NII) category has been subscribed 1,467.78 times. The NII category is further divided into bNII (bids above ₹10 lakh) with 1,780.71 times subscription and sNII (bids below ₹10 lakh) with 841.91 times subscription. NII category includes high net-worth individuals (HNIs) and corporate entities investing above ₹2 lakh. The subscription data helps analyze the interest level from high-value investors in Modern Diagnostic & Research Centre IPO IPO.

How can I check my Modern Diagnostic & Research Centre IPO IPO allotment status?

The basis of allotment date for Modern Diagnostic & Research Centre IPO IPO will be announced soon. You can check your allotment status by visiting the registrar's website (MUFG Intime India Pvt.Ltd) and entering your PAN number, application number, or DP ID. Alternatively, you can check through your demat account or the stock exchange website (NSE/BSE).

When will Modern Diagnostic & Research Centre IPO IPO be listed and on which exchange?

The listing date for Modern Diagnostic & Research Centre IPO IPO will be announced after the basis of allotment is finalized. The shares will be listed on BSE SME platform. After listing, you can trade the shares through your demat account.

What does the subscription rate mean for Modern Diagnostic & Research Centre IPO IPO?

The subscription rate (also called subscription multiple) indicates how many times the IPO has been oversubscribed. For Modern Diagnostic & Research Centre IPO IPO, the current subscription of 826.00 times means investors have bid for 826.00 times the number of shares offered. Since the subscription is above 1×, the IPO is fully subscribed. The high subscription indicates strong investor demand for Modern Diagnostic & Research Centre IPO shares. Higher subscription rates generally suggest strong market interest, but may also reduce individual allotment probability.

Should I invest in Modern Diagnostic & Research Centre IPO IPO?

Investment decisions should be based on your own research, risk appetite, and financial goals. The Modern Diagnostic & Research Centre IPO IPO has received 826.00 times subscription, indicating strong investor interest. Before investing, consider factors such as the company's business model, financial performance, industry outlook, price band valuation, and your investment objectives. It is recommended to consult with a financial advisor and read the Red Herring Prospectus (RHP) before making any investment decision. Past performance and subscription data are not indicative of future returns.

Understanding Modern Diagnostic & Research Centre IPO Subscription Data

QIB Subscription

Qualified Institutional Buyers (QIBs) typically include foreign institutional investors (FIIs), domestic financial institutions, banks, insurance companies, and mutual funds. QIB subscription is often a key indicator of institutional investor confidence in the IPO. For Modern Diagnostic & Research Centre IPO, the QIB category subscription stands at 271.13 times.

NII Subscription Breakdown

Non-Institutional Investors are high net-worth individuals and corporate entities investing above ₹2 lakh. The NII category is subdivided into bNII (bids above ₹10 lakh) and sNII (bids between ₹2 lakh and ₹10 lakh) to provide detailed insights into subscription patterns. For Modern Diagnostic & Research Centre IPO, bNII subscription is 1,780.71 times, while sNII subscription is 841.91 times.

Retail Subscription

Retail Individual Investors can apply for shares up to ₹2 lakh in an IPO. Retail subscription is often the most closely watched metric as it reflects the interest of small investors. For Modern Diagnostic & Research Centre IPO, retail subscription is 867.23 times. Higher retail subscription typically indicates strong retail investor interest and may impact allotment probability.

Investment Details

The Modern Diagnostic & Research Centre IPO has a price band of ₹85 to ₹90 per share, with a lot size of 1,600 shares. Retail investors can apply with a minimum investment of ₹136,000 (at lower price) or ₹144,000 (at upper price).

Back to Modern Diagnostic & Research Centre IPO Details